These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 38846981)
1. Exploiting tertiary lymphoid structures gene signature to evaluate tumor microenvironment infiltration and immunotherapy response in colorectal cancer. Xu Z; Wang Q; Zhang Y; Li X; Wang M; Zhang Y; Pei Y; Li K; Yang M; Luo L; Wu C; Wang W Front Oncol; 2024; 14():1383096. PubMed ID: 38846981 [TBL] [Abstract][Full Text] [Related]
2. Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients. Zhang F; Zhang R; Zong J; Hou Y; Zhou M; Yan Z; Li T; Gan W; Lv S; Yang L; Zeng Z; Zhao W; Yang M Front Immunol; 2023; 14():1279789. PubMed ID: 37928532 [TBL] [Abstract][Full Text] [Related]
3. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer. An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD Front Immunol; 2022; 13():1049884. PubMed ID: 36420257 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer. Shen C; Chai W; Han J; Zhang Z; Liu X; Yang S; Wang Y; Wang D; Wan F; Fan Z; Hu H Front Immunol; 2023; 14():1213947. PubMed ID: 37965307 [TBL] [Abstract][Full Text] [Related]
5. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature. Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598 [TBL] [Abstract][Full Text] [Related]
6. Identification of a risk score model based on tertiary lymphoid structure-related genes for predicting immunotherapy efficacy in non-small cell lung cancer. Mei SQ; Liu JQ; Huang ZJ; Luo WC; Peng YL; Chen ZH; Deng Y; Xu CR; Zhou Q Thorac Cancer; 2024 May; 15(14):1119-1131. PubMed ID: 38558529 [TBL] [Abstract][Full Text] [Related]
7. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
8. Comprehensive Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B Front Immunol; 2022; 13():931906. PubMed ID: 35958598 [TBL] [Abstract][Full Text] [Related]
9. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer. Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225 [TBL] [Abstract][Full Text] [Related]
10. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer. Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z Front Immunol; 2022; 13():951455. PubMed ID: 36189298 [TBL] [Abstract][Full Text] [Related]
11. Analysis of Circular RNA-Related Competing Endogenous RNA Identifies the Immune-Related Risk Signature for Colorectal Cancer. Song W; Ren J; Wang C; Ge Y; Fu T Front Genet; 2020; 11():505. PubMed ID: 32582276 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective. Jia W; Yao Q; Wang Y; Mao Z; Zhang T; Li J; Nie Y; Lei X; Shi W; Song W Front Immunol; 2022; 13():1007426. PubMed ID: 36189217 [TBL] [Abstract][Full Text] [Related]
13. Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer: a multicenter retrospective cohort study. Lei JX; Wang R; Hu C; Lou X; Lv MY; Li C; Gai B; Wu XJ; Dou R; Cai D; Gao F Int J Surg; 2024 Sep; 110(9):5627-5640. PubMed ID: 38833363 [TBL] [Abstract][Full Text] [Related]
14. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma. Chen Y; He J; Jin T; Zhang Y; Ou Y J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762 [TBL] [Abstract][Full Text] [Related]
15. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer. Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405 [TBL] [Abstract][Full Text] [Related]
16. Tertiary Lymphoid Structures Gene Signature Predicts Prognosis and Immune Infiltration Analysis in Head and Neck Squamous Cell Carcinoma. Xing A; Lv D; Wu C; Zhou K; Zhao T; Zhao L; Wang H; Feng H Curr Genomics; 2024 Apr; 25(2):88-104. PubMed ID: 38751598 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma. Chen L; Lin J; Wen Y; Chen Y; Chen CB Front Oncol; 2023; 13():1291720. PubMed ID: 38023241 [TBL] [Abstract][Full Text] [Related]
18. A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy. Li X; Wan Z; Liu X; Ou K; Yang L Med Oncol; 2022 Jan; 39(4):43. PubMed ID: 35092511 [TBL] [Abstract][Full Text] [Related]
19. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer. Chen Q; Tang P; Huang H; Qiu X Front Immunol; 2022; 13():934124. PubMed ID: 35958575 [TBL] [Abstract][Full Text] [Related]
20. Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma. Ren Z; Wang Z; Gu D; Ma H; Zhu Y; Cai M; Zhang J Front Cell Dev Biol; 2021; 9():740455. PubMed ID: 34746134 [No Abstract] [Full Text] [Related] [Next] [New Search]